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Introduction
Decision making around multiple alternative healthcare inter-
ventions is increasingly based on meta-analyses of a network 
of relevant studies, which contribute direct and indirect evidence 
to different treatment comparisons1,2. Limitations in the design 
and flaws in the conduct of studies synthesized in network meta- 
analysis (NMA) reduce the confidence in the results: a treatment 
comparison in the network may be directly or indirectly informed 
by studies at high risk of bias. A relative treatment effect from 
NMA (hereafter the NMA effect estimate) is estimated as a 
linear combination of the available direct estimates of the 
treatment effect (i.e. the results from pairwise meta-analyses) 
and the indirect evidence on the treatment effect.
Salanti et al. suggested that in order to assess the impact of 
study deficiencies on an NMA effect estimate, the limitations of 
studies contributing to direct estimates should be considered 
jointly, taking into account their relative contribution to the overall 
NMA effect estimate3. The percentage contribution matrix plays 
a key role in this approach: a matrix that shows how much each 
direct effect contributes to the estimation of the NMA effect.
The percentage contribution matrix is derived from the abso-
lute contribution matrix. The absolute contributions of direct 
effects to an NMA effect is the projection matrix from a two-step 
NMA model4,5. In the first stage, all direct effects are derived 
from pairwise meta-analyses. In the second stage, the NMA effect 
estimates are produced as a linear combination of the derived 
direct effects. The respective projection matrix is called the 
H matrix and it is analogous to the hat matrix in a linear 
regression model. The elements in the H matrix can be viewed 
as generalized weights from pairwise meta-analysis, but they 
do not add up to 1 and depend on the precision of the available 
studies, the degree of between-study heterogeneity and the network 
structure.
To translate the entries of the H matrix into percentage contribu-
tions, Salanti et al. suggested normalizing the absolute entries 
of each row of H and interpret them as percentages3. However, 
H represents the flow of evidence in different paths; the weight 
of each path is assigned to each direct effect involved. Thus, 
ignoring the multiple occurrences of the same values by taking 
standardized absolute values is incorrect. In particular, such a 
process overestimates the contribution of comparisons involved 
in long paths and underestimates the weights of the shortest paths. 
In this paper, we address this issue and present a method that 
properly translates the entries of the H matrix into percentages. 
The methodology is based on the observation that the rows of 
the H matrix can be interpreted as flow networks4,6.
Motivating example
To illustrate the ideas presented in this paper, we will use 
a network of topical antibiotics for the treatment of chronic otitis 
media with ear discharge in patients with eardrum perforations7. 
This network was used in Salanti et al.3 and compares no treatment 
(x), quinolone antibiotic treatment (y), non-quinolone antibiotic 
treatment (u) and antiseptic treatment (v)7. The study outcome was 
the proportion of patients with persistent discharge from the ear 
after 1 week, measured using the odds ratio (OR). The network 
plot shown in Figure 1a shows that direct evidence exists for 
all comparisons except u versus x (non-quinolone antibiotic 
versus no treatment).
In order to assess the confidence that should be placed in an 
NMA effect estimate, Salanti et al. suggested considering the 
quality of all pieces of evidence that contributed to it3. For exam-
ple, the studies directly comparing ‘u versus v’ were judged to be 
at high risk of bias; however, in order to judge the quality of the 
NMA effect estimate of ‘u versus v’, we need to con-
sider the amount of data that these studies contributed to its 
estimation.
Methods
We first present the random-effects two-stage NMA model first 
described by Lu et al.5. We will employ a simplified version 
of the H matrix described by König et al.4 that does not take into 
account the correlation induced by multi-arm trials. We ignore this 
correlation for the sake of ease of interpretation of the entries in 
the H matrix; we discuss implications of multi-arm trials at the 
end of the Methods section. Taking advantage of previous find-
ings on how the flow of evidence can be considered in NMA4,6, 
we present an algorithm to decompose the flow in a network and 
subsequently approximate the percentage contributions of direct 
effect estimates for each NMA effect estimate.
Two-stage network meta-analysis model
Consider a network of T competing treatments. The set of 
treatments is denoted by V = {x, y, u, v, ...} and let x denote 
the reference treatment. The number of NMA effects to be 
estimated is ( )2T  but the estimation of T – 1 effects allows the 
derivation of the remaining effects via linear combination. We 
collect the T – 1 effects against the reference treatment x in 
a vector of basic parameters θ = (θxy,θxu,θxv, ...)′. In the case of 
a dichotomous outcome, θ is the parameter vector of all 
log-ORs compared to the common reference treatment x.
We assume that the distribution of effect modifiers is similar 
across comparisons and thus the transitivity assumption is 
plausible. The consistency assumption refers to the statistical 
manifestation of transitivity and implies that all sources of 
            Amendments from Version 1
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Figure  1.  Network  plot  for  the  network  of  topical  antibiotics 





treatment  effect  are  indicated  along  the  edges),  streams  (c) 
and  percentage  contributions  of  each  direct  comparison  (d). 
x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; 
v, antiseptic.
evidence are in agreement; this is expressed via the consistency 
equations
               θuv = θxv – θxu, for all u, v ∈ V
Let us denote the number of comparisons with direct data 
(that is, at least one direct study) with D. For simplification, con-
sider that there are no multi-arm studies. At the first stage of the 
NMA model, direct effects are estimated, using random-effects 
pairwise meta-analyses. The estimates of the direct effects are 
collected in a column vector θ^ D of length D; their estimated 
variances are collected in a diagonal D × D matrix VD. At the 
second stage, the NMA effects are estimated as
                                          =
N DHθ θ^ ^                             Equation 1
where H is
                            H = Y(X′(VD)–1X)–1X′(VD)–1                 Equation 2
Matrix X is a D × (T – 1) design matrix expressing the linear 
relationships between the available direct effects and the basic 
parameters and Y is a ( )2T  × (T – 1) design matrix that links 
the NMA estimates with the basic parameters. Note that X is 
identical to Y only when there are direct studies for all treatment 
comparisons in the network.
Matrix H is of dimensions ( )2T  × D and describes the influ-
ence of each direct effect (specified in the column) to an NMA 
effect (specified in the row). As Equation 2 implies, H is 
derived as a function of the variances of the direct effects θ^ D and 
the network structure; therefore, the exact (absolute) contribu-
tion of each direct comparison depends on the precision of the 
available direct data and the comparison’s connectivity to the rest 
of the network. Note that it resembles the hat matrix in a linear 
regression model.
Let us focus on a single row of the H matrix which, say, cor-
responds to the NMA effect estimate of ‘x versus y’ and is 
denoted by hxy. Elements of hxy are denoted by xyuvh  and show 
the absolute contribution of the direct effect Duvθ
^
 indicated in 
the subscript (‘u versus v’) to the ‘x versus y’ NMA effect Nxyθ^ . 
Consider our motivating example which examines the set of 
treatments V = {x, y, u, v}. Equation 1 implies that the NMA 
treatment effect for the ‘x versus y’ comparison is derived as a 
linear combination of the direct meta-analyses
   
N D D D D Dxy xy xy xy xy
xy uvxy yv xv yuxy yv xv yu uvh h h h hθ + += + +θ θ θ θ θ
^ ^ ^ ^ ^ ^
  
Equation 3
The element xyxyh  represents the absolute but also the 
percentage contribution xyxyp  of the direct evidence for the par-
ticular NMA effect. Assuming that the comparison ‘x versus y’ 
is not part of any multi-arm study, the evidence to derive the 
NMA effect estimate can be portioned into direct and indirect 
estimates
                       
(1 )N IDxy xyxy xyxyxy xyh hθ += −θ θ
^ ^ ^
               
Equation 4
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with Ixyθ^  denoting the indirect effect for the ‘x versus y’ com-
parison; hence xyxyp  = 
xy
xyh . While the percentage contribution 
of each direct effect to its NMA effect can be obtained as 
the diagonal of the H matrix, the percentage contributions of 
other direct relative effects via indirect evidence (e.g. the xyuvp  
percentage contribution of Duvθ
^
 to Nxyθ
^ ) cannot be easily derived 
from the absolute contributions (that is, from xyuvh ). In the 
next section we will present how the absolute contributions xyuvh  
could be translated to percentage contributions xyuvp .
To explain the method, we will continue focusing on one row 
of the H matrix, say hxy, corresponding to the ‘x versus y’ compari-
son. Box 1 includes the definitions, along with the notation, of some 
of the notions used in this paper.
Box 1. Definitions
Set of vertices
The set of vertices is defined as the set of treatments examined 
in the network, V = {x, y, u, v ...}.
Set of directed edges
The set of directed edges E is defined as the set of direct 
comparisons respecting the signs of the entries of hxy, the row 
of the H matrix corresponding to the ‘x versus y ’ comparison. 
Edges are given a direction upon the definition of flows; the 
network itself corresponds to an undirected graph.
Set of flows
The set of flows is defined as F = {fuv, ∀ uv ∈ E} where fuv is equal 
to |huv|.
Comparison graph
A comparison graph is defined as a graph Gxy = (V, E, F) 
constructed from a row of the H matrix, hxy; its definition derives 
from a set of vertices V, a set of edges E, and a set of flows, F.
Source
Source is defined as a vertex with no incoming edges.
Sink
Source is defined as a vertex with no outgoing edges.
Path
A path πi is defined as a sequence of connected directed edges 
belonging to E.
Stream
A stream Si is defined as the composition of a path and its 
associated flow, Si = (φi, πi). with i = 1, ... , I where I is the total 
number of streams.
Comparison graph
König et al. showed that every row of the H matrix, hxy, can be 
interpreted as a flow network with source x and sink y, and 
visualised in a directed acyclic graph (DAG)4. Thus, we create 
a graph Gxy = (V, E, F) from hxy; its definition derives from a 
set of vertices V, a set of edges E, and a set of flows, F. The set 
of vertices is defined as the set of treatments examined in the 
network, V = {x, y, u, v ...}. Set E is defined as a set of directed 
edges that correspond to observed direct comparisons respect-
ing the signs of the entries of hxy. To simplify the notation, we 
drop from now on all superscripts assuming they all refer to xy. 
Then, the set E contains uv if huv > 0 or contains vu if huv < 0. 
The set of flows is defined as F = {fuv, ∀ uv ∈ E} where fuv is 
equal to |huv|.
The following conditions hold for the elements of set F 
(see Supplementary File 1 for proof):
      a. The sum of outflows of node x (source) is 1








      b. The sum of inflows of node y (sink) is 1






      c.  The flow passing through each internal node (any node except 






f fz V x y
∈ ∈
∀ ∈ =∑ ∑
      d.  Gxy is acyclic; there is no path (sequence of edges) that visits 
the same vertex twice.
Consider, for example, the graph Gxy in Figure 1b, which 
corresponds to the xy comparison of the network of four treat-
ments of Figure 1a. The set of vertices is V = {x, y, u, v} and the 
set of directed edges is E = {xy, xv, vy, vu, uy}. Flows fuv are given 
along the edges; their numerical values are equal to the respec-
tive absolute entries of hxy and the direction of their corresponding 
edge is indicated in the subscript. As properties (a) to (d) imply, 
the arrows in Figure 1b indicate that the outflows of x, as well 
as the inflows of y, equal 1, and that the inflows equal the 
outflows in the intermediate nodes u and v.
Streams
In Figure 1b there are three different paths from x to y, one 
based on direct evidence, {xy}, and two based on indirect evi-
dence, {xv, vy} and {xv, vu, uy}. A path is a sequence of connected 
directed edges belonging to E, and we denote it as πi. As 
property (d) implies, each node occurs at most once in πi. Then, 
given the above properties of fuv, we can assign a flow φi to each 
path πi. Flow φi is equal to the smallest fuv in the path πi. Figure 1c 
shows the three paths from x to y; π1, π2 and π3, and their 
corresponding flows. Path π1 corresponds to xy and its flow, φ1, 
equals the flow of the single edge in path, fxy = 0.635. Path π2 is 
constituted from two edges, xv and vy; thus, flow φ2 = min(fxv, fvy) = 
0.251. The flow corresponding to the third path π3 is 
φ3 = min(fxv, fvu, fuy) = 0.114.
We define a stream, Si, as the composition of a path and its 
associated flow, Si = (φi, πi) with i = 1, ..., I where I is the total 
number of streams; here I = 3. Note that it holds 1 =1iϕ∑Ii=  .
Percentage contributions of direct comparisons
In order to assign percentage contributions to each direct 
comparison, we need to split each stream’s flow to the involved 
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edges in the stream’s path. It can be shown that an NMA 
effect is a linear combination of the direct effects combined 
within paths. More specifically, Equation 3 can be re-written as
  
( ) ( )N D D D D D Dxy uvxy xv yv xv yu31 2θ + += ϕ ϕ − ϕ − −θ θ θ θ θ θ
^ ^ ^ ^ ^ ^ ^




1 1ii= ϕ =∑ . Equation 5 represents (1 )N IDxy xyxy xyxyxy xyh hθ += −θ θ
^ ^ ^
 as a weighted sum of 
direct and two indirect effect estimates; the effects are stochasti-
cally interdependent and, hence, their aggregation is different from 
the aggregation of studies in a pairwise meta-analysis.
To approximate the percentage contributions per comparison, 
we suggest dividing φi by the length of the respective path πi, 
#πi. This will leave the percentage contribution of the direct evi-
dence of the same treatment comparison equal to the diagonal 
of the H matrix and assign to each comparison involved in an 
indirect route a portion of the respective stream’s flow. Note 
that directed edges might be involved in more than one path; we 











Figure 1d shows the derivation of the percentage contributions 
of each direct comparison in the network of topical antibiot-
ics. Hence, from the row of the H matrix (0.635, 0.365, –0.114, 
–0.251, –0.114), which shows the absolute contributions of 
the direct effects ^ ^ ^ ^ ^D D D D Duvxy x yv yuv, , , ,θ θ θ θ θ  to 
^ N
xyθ , we approximated 
their percentage contribution as 63.5%, 16.4%, 3.8%, 12.6% and 
3.8%, respectively.
Algorithm to decompose flows into percentage contributions
In this section, we present an iterative algorithm that generalizes 
the process outlined above to derive percentage contributions of 
each direct effect to the estimation of a ‘x versus y’ NMA effect. 
We start by defining a graph Gxy from hxy.
The algorithm is described as follows:
0.     Set initial graph G0 = (V, E0, F0) = Gxy. E0 contains uv if 
huv > 0 or contains vu if huv < 0. The set of flows is 
F0 = {f0,uv | uv ∈ E0}; numerical values of f0,uv are equal to huv.
Then, repeat the process below I times, equal to the number of 
streams in Gi, until Ei = {Ø}.
1.     In Gi–1, find the shortest path from x to y, πi, and define its 
flow as φi = min{fi–1,uv, uv ∈ πi}. Then, use πi and φi to define 
the stream Si = (φi, πi).
2.     Recalculate the flow of edges uv ∈ πi by subtracting φi 
from the flow of the edges of the stream found: fi,uv = fi–1,uv – φi 
∀ uv ∈ πi. The flow of the rest of the edges that do not 
belong to πi remain unchanged: fi,uv = fi–1,uv ∀ uv ∉ πi.
3.     Define Ei as the set of edges uv for which fi,uv > 0; this is 
Ei–1 after removing the edges with zero flow, Ei = 
Ei–1\{uv | fi,uv = 0}. Collect fi,uv to form the set Fi = {fi,uv | uv ∈ Ei}.
4.    If Ei ≠ {Ø} define Gi = (V, Ei, Fi) and go to step 1.
When the algorithm terminates, all streams Si = (φi, πi) have 
been identified and Equation 6 is used to derive the percentage 
contributions puv.
Repeating the same process for all NMA effects, we 
derive all xyuvp  and collect them in a matrix P of the same dimen-
sions as H. The presented algorithm could be described as 
a reverse maximum flow Edmonds Karp algorithm8, but instead 
of adding we remove augmenting paths.
It is possible that multiple shortest paths exist; in this case, 
the order in which one chooses such a path could in principle result 
in different percentage contributions per comparison. We can, 
thus, use the following modification in the algorithm to impose 
consistency. Instead of selecting the shortest path, we assign 
cost values ci,uv to each edge uv as follows: ci,uv = 2 – fi–1,uv. Then, 
we select the path from x to y with the minimum cost across 
comparisons included in πi. The definition of the cost values 
ci,uv assures that paths are selected from shortest to longest and 
removes any ambiguity regarding the selection of paths.
The starting point for the developed algorithm was a simplified 
version of the H matrix that does not consider the correlation 
induced by multi-arm trials. Alternatively, one could use the 
the H matrix as described by König et al.4 that extends the defi-
nition of the matrix for multi-arm designs. Note that any matrix 
whose rows can be interpreted as flow networks can be used 
as the starting point of the algorithm.
Calculations in this paper were performed using R.
Application
We apply the algorithm described above to the network of 
topical antibiotics7.
Percentage contributions of direct relative treatment effects 
to the estimation of the NMA effect between non-quinolone 
antibiotic and no treatment
Direct effects are obtained using the random effects model 
and the H matrix of dimension 6×5 is calculated using Equation 2. 
The H matrix, along with NMA effects, is given in Table 1.
We begin by applying step 0 of the algorithm. We construct 
the network G0 = Gxy = (V, E0, F0) with source x and sink y 
corresponding to row hxy. The set of vertices is V = {x, y, u, v} 
and the set of directed edges, taking into account the signs of the 
elements of hxy, is E0 = {xy, xv, vy, vu, uy}. The set of flows is 
F0 = {f0,uv | uv ∈ E0}, where f0,uv equal the respective absolute 
values of Table 1 and are given along the edges of Figure 1b.
Then, we apply the developed iterative algorithm until 
Ei = {Ø}. The iterations of the algorithm equal the number of 
existing streams from x to y and are illustrated in Figure 2.
First iteration
1.    In G0, find the shortest path from x to y, π1 = {xy}. Define 
its flow as φ1 = min{f0,uv, uv ∈ π1} = f0,xy = 0.635. Define 
stream S1 = (φ1, π1) (Figure 2a).
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2.    Recalculate the flow of edge xy ∈ π1 as f1,xy = f0,xy – φ1 = 
0.635 – 0.635 = 0. The flow of the rest of the comparisons 
remains unchanged: f1,uv = f0,uv ∀ uv ∉ π1 (Figure 2b).
3.    Define E1 as the set of edges uv for which f1,uv > 0; edge 
xy is removed since its flow is zero, E1 = E0\{xy}. Collect 
f1,uv to form the set F1 = {f1,uv | uv ∈ E1} (Figure 2c).
4.    Define G1 = (V, E1, F1). As E1 = {xv, vy, vu, uy} ≠ {Ø}, 
go to step 1 (Figure 2c).
Second iteration
1.    In G1, find the shortest path from x to y, π2 = {xv,vy}. 
Define its flow as φ2 = min{f1,uv, uv ∈ π2} = f1,vy = 0.251. 
Define stream S2 = (φ2, π2) (Figure 2d).
2.    Recalculate the flow of edges xv and vy as f2,xv = f1,xv – φ2 = 
0.365 – 0.251 = 0.114 and f2,vy = f1,vy – φ2 = 0.251 – 0.251 = 0. 
The flow of the rest of the comparisons remains 
unchanged: f2,uv = f1,uv ∀ uv ∉ π2 (Figure 2e).
3.    Define E2 as the set of edges uv for which f2,uv > 0; edge vy 
is removed since its flow is zero and thus E2 = E1\{vy}. 
Collect f2,uv to form the set F2 = {f2,uv | uv ∈ E2} (Figure 2f).
4.    Define G2 = (V, E2, F2). As E2 = {xv, vu, uy} ≠ {Ø}, go to 
step 1 (Figure 2f).
Third iteration
1.    In G2, find the shortest path from x to y, π3 = {xv, vu, uy}. 
Define its flow as φ3 = min{f2,uv, uv ∈ π3} = 0.114. Define 
stream S3 = (φ3, π3) (Figure 2g).
2.    Recalculate the flow of edges xv, vu and uy as f3,xv = f3,vu = 
f3,uy = f2,xv – φ3 = 0.114 – 0.114 = 0 (Figure 2h).
3.    Define E3 as the set of edges uv for which f3,uv > 0; 
edges xv, vu and uy are removed since their flow is zero, 
E3 = E2\{xv, vu, uy}. Collect f3,uv to form the set 
F3 = {f3,uv | uv ∈ E3} (Figure 2i).
4.    Define G3 = (V, E3, F3). The set of direct edges is E3 = {Ø} 
and the algorithm is terminated at this point (Figure 2i).
Figure 1c shows the flows of the three streams identified when 
applying the above algorithm. We then calculate the percentage 
contributions of each comparison to the ‘x versus y’ NMA 
treatment effect estimate using Equation 6 (Figure 1d). For 
instance, to calculate p
xv
 we first have to identify the relevant 
paths; these were π2 and π3. Consequently,
          




ϕ ϕ= + = + = =
π π
The calculations for deriving the percentage contributions 
of the other comparisons are shown in Table 2. Applying the 
algorithm to all NMA treatment effect estimates we get the 
entire percentage contribution matrix P.
Percentage study contributions
Matrix P (Table 3) shows the percentage contributions of each 
direct comparison to each NMA treatment effect estimate. 
These percentages can be distributed to individual studies within 
each comparison according to their weights from direct meta- 
analyses. For example, p
xy = 63.5% and there are two studies 
examining the xy comparison. The individual study weights 
for the two studies are 0.69 and 1.54 resulting in study percent-






to the xy NMA treatment effect estimate. The application of this 
process to the entire matrix P leads to the matrix P* shown in 
Table 4. Adjusted weights as proposed by Rücker & Schwarzer9 
are used for multi-arm studies.
Using percentage study contributions to quantify the 
impact of a characteristic in a direct comparison
The algorithm translating the H matrix into study percent-
age contributions can be applied to quantify the influence 
that a study-level characteristic has in the estimation of the 
NMA effects. For instance, if risk of bias judgements for indi-
vidual studies are available, we can obtain an approximation 
of the percentage of each NMA treatment effect estimate that 
is coming from studies with a ‘high’, ‘moderate’, or ‘low’ 
risk of bias. Salanti et al. suggested the visualisation of this 
information using a bar plot, in which direct comparisons 
Table 1. H matrix in the network of topical antibiotics without steroids for chronically 
discharging ears. Columns correspond to direct comparisons and rows correspond to network 
meta-analysis (NMA) effects. Direct effects along with their variances and NMA effects with 95% 
confidence intervals (CIs) are given in the last column. Direct and NMA effects are measured as 
log odds ratios. Positive values favour the first treatment.




xy 0.635 0.365 –0.114 –0.251 –0.114 –2.29 0.42 –1.86 (–3.05,–0.67)
xu 0.603 0.397 0.632 –0.029 –0.368 – – –1.32 (–2.61,–0.02)
xv 0.545 0.455 0.170 0.375 0.170 0.35 0.63 –0.72 (–1.95,0.52)
yu –0.032 0.032 0.745 0.223 –0.255 0.39 0.12 0.54 (–0.07,1.16)
yv –0.090 0.090 0.284 0.627 0.284 1.24 0.15 1.14 (0.47,1.81)
uv –0.058 0.058 –0.462 0.404 0.538 0.53 0.22 0.60 (–0.12,1.33)
x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic.
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Figure 2.  Illustration of  the steps of  the algorithm  for approximating percentage contributions per comparison  in  the network of 
topical antibiotics without steroids for chronically discharging ears focusing on the comparison ‘x versus y’. Treatment labels: x, no 
treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic.
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Table 2. Percentage contributions of direct comparisons to the ‘x versus y’ network meta-analysis 
treatment effect in the network of topical antibiotics without steroids for chronically discharging ears.




























x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic.
Table 3. Percentage contribution matrix P for the 
network of topical antibiotics without steroids 
for chronically discharging ears. Cells show the 
percentage contribution of direct comparisons 
indicated in the column to the network meta-analysis 
treatment effects indicated in the rows.
xy xv yu yv uv
xy 63.5% 16.4% 3.8% 12.6% 3.8%
xu 30.1% 19.4% 31.1% 1% 18.4%
xv 24.4% 45.5% 5.7% 18.8% 5.7%
yu 1.1% 1.1% 74.5% 11.1% 12.2%
yv 4.5% 4.5% 14.2% 62.7% 14.2%
uv 1.9% 1.9% 22.1% 20.2% 53.8%
x, no treatment; y, quinolone antibiotic; u, non-quinolone 
antibiotic; v, antiseptic.
Table 4. Study percentage contribution matrix P* for the network of topical antibiotics without steroids for chronically 
discharging ears. Cells show the percentage contribution of individual studies indicated in the column to the network meta-analysis 
treatment effects indicated in the rows.







xy 19.7 63.4 2.8 0.5 0.6 0.4 0.6 0.7 2.7 1.3 0.8 2.3 4.2
xu 9.3 40.4 8.8 4.4 5.3 3.5 5.1 5.4 6.9 6.5 3.9 0.2 0.3
xv 7.6 67.1 4.2 0.8 1 0.6 0.9 1 4.1 2 1.2 3.4 6.2
yu 0.3 4.63 13.6 10.5 12.7 8.4 12.2 12.9 12.2 4.3 2.6 2 3.7
yv 1.4 23.5 12.1 2 2.4 1.6 2.3 2.4 12.2 5 3 11.3 20.7
uv 0.6 8.4 19 3.1 3.8 2.5 3.6 3.8 14.4 19.1 11.5 3.6 6.7
x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic. 
of the same risk of bias level have been grouped3. Figure 3 
shows such a bar plot using the algorithm described in this paper 
and distributing comparison percentage contributions to study 
percentage contributions; inspecting Figure 3 can support judge-
ments regarding the importance of study limitations for different 
NMA treatment effect estimates. For instance, studies with high 
risk of bias contribute more than 50% in the estimation of the 
‘u versus v’ comparison, potentially reducing the confidence that 
we can place in this particular NMA treatment effect estimate.
Percentage contributions of direct comparisons in a large 
complex network of interventions
So far, we have illustrated how to derive percentage contribu-
tions for a network with four treatments. However, the algo-
rithm can be straightforwardly applied to large networks of any 
structure, as soon as the involved treatments are connected. Con-
sider for example a large network examining antimanic drugs 
(Figure 4)11. Let us concentrate on the comparison PLA versus 
OLA (‘placebo versus olanzapine’); the algorithm starts by 
applying step 0 and constructing network G0. Then, we continue 
by finding the shortest path in the first iteration, which 
corresponds to the direct comparison, and define its flow and 
stream S1 = (φ1, π1). The number of algorithm’s iterations is 
equal to the number of streams from placebo to olanzapine, 
which turns out to be 16. The resulting entire percentage matrix 





Data labels: study, name of individual studies; id, id of the individual 
studies; t; treatment; r, number of events; n, sample size; rob, risk of 
bias per study.
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Figure 4. Network plot  for  the network of antimanic drugs. ASE, asenapine; ARI, aripiprazole; PLA, placebo; HAL, haloperidol; QUE, 
quetiapine; LITH, lithium; ZIP, ziprasidone; OLA, olanzapine; DIV, divalproex; RIS, risperidone; CARB, carbamazepine; LAM, lamotrigine; PAL, 
paliperidone; TOP, topiramate; ASE, asenapine.
Figure 3. Bar plot showing the study percentage contributions of direct comparisons with low (green), moderate (yellow) and high 
(red) risk of bias. The bar plot has been produced in CINeMA (Confidence In Network Meta-Analysis) software12. Studies are synthesized 
using the random effects model. x, no treatment; y, quinolone antibiotic; u, non-quinolone antibiotic; v, antiseptic.
Discussion
In this paper, we present a new approach to derive percent-
age contributions of individual studies to the treatment effect 
estimates in NMA. We made use of the fact that the composition of 
network treatment effect estimates can be interpreted as a flow of 
evidence. An assumption that underlies our algorithm is the equal 
split of the stream flow to the involved comparisons. Although 
indirect effects are not weighted averages, we find this approxi-
mation to be a pragmatic approach that reasonably reflects the 
amount that each comparison contributes to network effects. 
Applying the algorithm to networks of interventions can be used 
to quantify the contribution of potential study limitations to the 
NMA treatment effect estimates. Study limitations may lead to 
biased NMA treatment effect; however, the amount and direc-
tion of bias in the NMA treatment effect as a result of the 
within-study bias is not straightforward to define and is not cur-
rently accommodated within the percentage contribution matrix. 
First, a single biased trial may affect an entire indirect route; thus, 
even if its percentage contribution is small, its consequences in 
the estimation of the NMA treatment effect may be important. 
Second, the direction of bias across studies involved in a stream 
may vary. For example, bias in two comparisons in the same 
stream may either cancel out or add-up in favor of one of the two 
treatments. We aim to extend the methods presented in this paper 
to develop a network meta-regression model that will use the 
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direction and the amount of bias to determine whether and how 
much NMA treatment effect estimates will be biased as the 
result of within-study bias.
Alternative methods to derive the relative contribution of all 
sources of evidence have been developed4,12,13,14. An alterna-
tive approach has been proposed to derive percentage study 
weights in a variety of meta-analysis models, including meta- 
regression, network meta-analysis and individual patient data 
meta-analysis10. This approach is based on the decomposition of 
Fisher’s information matrix and thus the derived weights are 
not influenced by the network structure. Further investigation 
of the degree of agreement between our algorithm and that of 
Riley et al.10 would be of interest.
In the example implemented in the Application, there is 
no other possible set of paths, and associated streams, that 
could be selected from x to y in order to partition the inflow of 
x: π1, π2 and π3 is the only possible set of streams (Figure 1c). 
Thus, even if we were taking paths using different criteria, i.e. 
from longest to shortest, according to values from the H matrix 
or even randomly, the percentage contributions given in Table 2 
would be identical. However, cases exist where the selection of 
paths does influence the derivation of the P matrix. In 
Supplementary File 3, we elaborate on the selection of direct 
paths in the algorithm and discuss some alternative modifica-
tions of the algorithm. We are planning to examine the properties 
of the different approaches in greater detail in a follow up 
project.
We offer an R package11, which we also use in the software 
application CINeMA (Confidence In Network Meta-Analysis)12, 
that aims to simplify the evaluation of confidence in the findings 
from NMA. While CINeMA largely follows the framework pre-
viously developed by Salanti et al.3, the refinement of several 
methodological aspects is currently under development. Core 
aspects of the approach include the consideration of the rela-
tive contributions of each direct comparison to each NMA treat-
ment effect estimate. To this end, CINeMA uses the percentage 
contribution matrix as described in this paper. The command 
netweight in Stata has also been updated to use the described 
approach.
We believe that the approach described in this paper is a useful 
and novel addition to network meta-analysis methodology, which 
allows the consistent derivation of the percentage contribu-
tions of direct evidence from individual studies to network 
treatment effects.
Data availability
Dataset 1: Outcome data from the example network of 
topical antibiotics for the treatment of chronic otitis media 
with ear discharge in patients with eardrum perforations7. 
Data labels: study, name of individual studies; id, id of the 
individual studies; t; treatment; r, number of events; n, sample 
size; rob, risk of bias per study. DOI: 10.5256/f1000research. 
14770.d20317413.
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Supplementary material
Supplementary File 1. Proof that the sum of all outflows from the source is equal to the sum of all inflows to the sink and both 
are 1.
Click here to access the data.
Supplementary File 2. Percentage contribution matrix P for the network of antimanic drugs. Cells show the percentage contri-
bution of direct comparisons indicated in the column to the network meta-analysis treatment effects indicated in the rows. ASE, 
asenapine; ARI, aripiprazole; PLA, placebo; HAL, haloperidol; QUE, quetiapine; LITH, lithium; ZIP, ziprasidone; OLA, olanzapine; 
DIV, divalproex; RIS, risperidone; CARB, carbamazepine; LAM, lamotrigine; PAL, paliperidone; TOP, topiramate; ASE, asenapine.
Click here to access the data.
Supplementary File 3
Considerations on the selection of streams
Click here to access the data.
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1. The authors undertake a redefinition of the term ‘percentage contribution’ in network
meta-analysis. In ordinary meta-analysis of randomized clinical trials, pooled estimates of
a treatment effect can be represented as a weighted mean of treatment effects from all
contributing trials. Weights are positive and sum to one and naturally constitute the
‘percentage contribution’ of each study. In network meta-analysis treatment effect
estimates are defined for all pairs of treatments. Each can be represented as a two-stage
estimate, firstly pooling all trials comparing the same set of treatments, respectively,
which gives direct effect estimates, and then pooling direct estimates into a network
based mixed treatment comparison. The linear coefficients, used in the second stage
constitute the ‘contribution of direct evidence to a network based comparison’. They can
be read off, from the H matrix, as described by the authors. They share some but not all
aspects with weights of a two-armed meta-analysis. Aspects shared in some sense are
the flow properties described by the authors and in citation [4]. The aspect not shared, is
that summation to one.
Indeed, in a purely linear graph connecting two extreme treatments through a chain of,
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 Indeed, in a purely linear graph connecting two extreme treatments through a chain of,
say 10, pairwise intermediary comparisons, the network estimate is the sum of all direct
effects. Any bias present in one direct effect estimate translates 1:1 into the network
based estimate. Accordingly, the entries of the H matrix are all equal to 1 in the relevant
row.
Both, Salanti [3] and the present paper aim to rescale or transform the rows of the H
matrix in order to achieve a ‘sum to one’ condition. In the case of the linear graph, the
percentage contribution is 10% for each direct comparison. I am not convinced, that this
number adequately captures the role of each direct effect estimate in this example.
Consider now, an example where two treatments are connected through three paths with
one, two, and three edges, respectively, each with flow 1/3. Then each direct comparison
has the same influence on the network based treatment effect estimate: A bias of 1 unit in
one direct estimate translates into a bias of 1/3 unit in the network based estimate. These
proportions are conserved in Salanti’s notion of percentage contribution, but not so in the
newly introduced concept. Salanti [3] attaches a percentage contribution of 1/6 to each
comparison just as if we had pooled six equally precise trials comparing the same pair of
treatments. But the influence of direct comparisons is different in this network and should
be characterized by the number 1/3.
That is why I have objections against Salanti’s [3] concept of percentage contribution and
even more so against the newly introduced concept, which attaches unequal contribution
quantities of 1/9, 1/6 and 1/3, respectively.
The new method should not be introduced into routine of network meta-analysis. If this























Page 19 of 24








2. The concept of streams is a nice one. It allows to represent a network based treatment
effect as a weighted sum of a direct and indirect effect estimates each corresponding to
one path from source to sink. Note however that these effects are stochastically














3. To be somewhat less destructive, I propose to arrange the network graph with the
source to the left and the sink to the right and all other vertices placed, such that all
directed edges point from left to right. Then, due to the flow properties, any vertical
cross-section gives a set of flows that sum to one. In that sense, the untransformed rows
of the H matrix already contain percentage contributions. Displays used to present voter





4. I propose to modify Table 3 and Figure 3 in a way that the direction of influence
becomes clear. Does a positive bias in one contributing direct effect translate into a
positive or negative bias of the network based effect estimate? The colored fields in
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5. Discussion “The calculation of the percentages uses the estimated variances of direct
effects and thus incorporate associated uncertainty in their estimation.”
Note however, that in a linear network each direct effect estimate contributes equally,










6. Discussion “Applying the algorithm to networks of interventions can be used to
quantify the contribution of potential study limitations to the NMA treatment effect
estimates.”
The two stage approach discussed in this paper is not essential. Both the flows and the
percentage contribution defined in the paper can be distributed to single trials according
to the weights used when pooling them into direct effect estimates. Then the risk of bias
of single trials can be analyzed. A display similar to Figure 3 is possible that contains
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7. Discussion, 2  paragraph: Concerning multi-armed designs, König et al.[4] have
























2nd paragraph: ‘The number of directed paths’ obviously refers to the number of directed
paths „which suffice to ‘spend’ the flow from source to sink”. 
Thank you, we corrected it. 
The authors state that, if no bridges exist, this number equals to df+1. However, it
depends on the flows, too. Consider a network composed of two squares connected at
one vertex. It has df=2 inconsistency degrees of freedom and generally 3 paths are
needed to spend the flow between the two most distant vertices. However, if all edges
have equal flows, only two paths are needed. Moreover, the connecting vertex has the
same effect as the bridging edges. Hence the argument has to be extended to the case of
graphs that can be split by cutting through a vertex.
nd
xy
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 graphs that can be split by cutting through a vertex.
Note also, that a network estimate that compares treatments from different subgroups of
treatments connected through a bridge or a ‘breaking’ vertex can be written as the sum of
three respective two subnetwork effect estimates: one comparing the source treatment to
the bridge post, one for the bridge, if present, and one comparing the second bridge post
to the sink. Because it is an unweighted sum, the contribution of the three (or two)
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